KaydedilenlerDerginizi ekleyin

Dergiler / Journal of Experimental and Clinical Medicine / 2012 / Cilt: 29 - Sayı: 1

Bilateral central retinal vein occlusion in non-Hodgkin lymphoma and the effects of intravitreal bevacizumab injection

Ebru CÖMERT
Yuksel SULLU
Sayfa
80–82
Yayın Tarihi
2012-04-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Intravitreal bevacizumab injection is as an effective treatment for intraretinal and subretinal edema in central retinal vein occlusion secondary to non-Hodgkin lymphoma.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:The purpose of this study is to report bilateral central retinal vein occlusion in a patient with non-Hodgkin lymphoma and the effects of intravitreal bevacizumab injection.
📊
Temel Bulgular & Veri:Bilateral central retinal vein occlusion was observed in the patient because of hyperviscosity due to non-Hodgkin lymphoma which resulted in decreased visual acuity and increased macular thickness.
💡
Sonuç & Katkı:Intravitreal bevacizumab injection is as an effective treatment for intraretinal and subretinal edema in central retinal vein occlusion secondary to non-Hodgkin lymphoma.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Non-Hodgkin lymphoma · Central retinal vein occlusion · Intravitreal bevacizumab

Abstract

The purpose of this study is to report bilateral central retinal vein occlusion in a patient with non-Hodgkin lymphoma and the effects of intravitreal bevacizumab injection. This is a case report of a patient seen and treated in the ophthalmology department of Ondokuz Mayıs University Medical Faculty. Bilateral central retinal vein occlusion was observed in the patient because of hyperviscosity due to non-Hodgkin lymphoma which resulted in decreased visual acuity and increased macular thickness. Bilateral intravitreal bevacizumab injection increased best corrected visual acuity increased and reduced intraretinal, subretinal edema markedly. A hyperviscosity syndrome or inflammatory condition should be suspected when a patient, less than 50 years, has bilateral and simultaneous central retinal vein occlusion. Intravitreal bevacizumab injection is as an effective treatment for intraretinal and subretinal edema in central retinal vein occlusion secondary to non-Hodgkin lymphoma.

🔖

Bu Makaleye Atıf Yap

CÖMERT, E., SULLU, Y. (2012). Bilateral central retinal vein occlusion in non-Hodgkin lymphoma and the effects of intravitreal bevacizumab injection. Journal of Experimental and Clinical Medicine, Cilt: 29 - Sayı: 1, 80–82. https://ajindex.com/articles/678893

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Cheung, C.M., Tsaloumas, M.D., 2002. Acute myeloid leukaemia presenting as retinal vein occlusion and eyelid swelling. Eye.16, 202-203.
  2. Friedman, A.H., Marchesky, A., Odel, J.G., Gerber, M.A., Thung, S.N., 1980. Immunofluorescent studies of the eye in Waldenstrom's Macro- globulinemia. Arch. Ophthalmol. 98, 743-746.
  3. Grindle, C.F., Buskard, N.A., Newman, D.L., 1976. Hyperviscosity retinopathy, a scientific approach to therapy. Trans. Ophthal. Soc. 96, 216- 219. Hayreh, S.S., Zimmerman, M.B., Podhajsky, P., 2002. Hematologic abnormalities associated with various types of retinal vein occlusion. Graef- es Arch. Clin. Exp. Ophthalmol. 240, 180-196.
  4. Hayreh, S.S., 2003. Management of central retinal vein occlusion. Ophthalmologica. 217, 167-188.
  5. Iturralde, D., Spaide, R.F., Meyerle, C.B., Klancnik, J.M., Yannuzzi, L.A., Fisher, Y.L., Sorenson, J., Slakter, J.S., Freund, K.B., Cooney, M., Fine, H.F., 2006. Intravitreal bevasizumab treatment of macular edema in central retinal vein occlusion: A shorter-term study. Retina. 26, 279-284.
  6. Jaissle, G.B., Ziemssen, F., Petermeier, K., Szurman, P., Ladewig, M., Gelisken, F., Völker, M., Holz, F.G., Bartz-Schmidt, K.U., 2006. Bevaci- zumab for treatment of macular edema secondary to retinal vein occlusion. Ophthalmol. 103, 471-475.
  7. Kahook, M.Y., Schuman, J.S., Noecker, R.J., 2006. Intravitreal bevacizumab in a patient with neovascular glaucoma. Ophthal. Surg. Las. Im. 37, 144-146.
  8. Priglinger, S.G., Wolf, A.H., Kreutzer, T.C., Kook, D., Hofer, A., Strauss, R.W., Alge, C.S., Kunze, C., Haritoglou, C., Kampik, A., 2007. Intra- vitreal bevacizumab injections for treatment of central retinal vein occlusion. Retina. 27, 1004-1012.
  9. Rosenfeld, P.J., Fung, A.E., Puliafito, C.A., 2005. Optical coherence tomography findings after an intravitreal injection of bevacizumab for macular edema from central retinal vein occlusion. Ophthal. Surg. Las. Im. 36, 336-339.
  10. Spalter, H.F., 1959. Abnormal serum proteins and retinal vein thrombosis. Arch. Ophthalmol. 52, 868-881. The Central Vein Occlusion Study Group, 1997. Natural history and clinical management of central retinal vein occlusion. Arch. Ophthalmol. 115, 486-491.
  11. Williamson, T.H., 1997. Central retinal vein occlusion: What’s the story? Br. J. Ophthalmol. 81, 698-704.